Topic: Reuters Group plc
SAN DIEGO (Reuters) - Scientists have for the first time created blood platelet cells by reprogramming stem cells derived from adult cells, offering the potential for a renewable supply of the fragile blood component.Researchers at the Center for iPS Cell Research and ...
LONDON (Reuters) - British scientists have developed a new stem cell technique for growing working liver cells which could eventually avoid the need for costly and risky liver transplants.A team of researchers led by the Sanger Institute and the University of Cambridge ...
CHICAGO (Reuters) - U.S. scientists for the first time have used a cloning technique to get tailor-made embryonic stem cells to grow in unfertilized human egg cells, a landmark finding and a potential new flashpoint for opponents of stem cell research.The researchers ...
WASHINGTON (Reuters) - A U.S. judge on Wednesday upheld the federal government's rules that allow funding of human embryonic stem cell research, ruling for the Obama administration.U.S. District Judge Royce Lamberth ruled the U.S. National Institutes of Health (NIH) guidelines on such ...
PARIS (Reuters) - France looked set on Thursday to maintain its curbs on human embryonic stem cell research after the conservative government fought off a parliamentary bid to liberalize the country's bioethics law.The National Assembly voted to uphold the curbs in the ...
WASHINGTON (Reuters) - The Obama administration can continue using federal tax dollars to fund human embryonic stem cell research, an appeals court ruled on Friday, overturning a judge's decision and handing a victory to the White House.A federal judge ruled last year ...
WASHINGTON (Reuters) - The Obama administration can continue using federal tax dollars to fund human embryonic stem cell research, a U.S. appeals court ruled on Friday, overturning a lower court decision and handing a victory to the White House.A federal judge ruled ...
WASHINGTON (Reuters) - Christopher Goodrich of Portland, Oregon, can't wait to stick a needle in his eye.Goodrich hopes to be one of the first patients enrolled in clinical trial that just got a go-ahead from the U.S. Food and Drug Administration, only ...
WASHINGTON (Reuters) - The U.S. Food and Drug Administration has approved the second human trial of human embryonic stem cells -- this one testing cells in people with a progressive form of blindness, the company said on Monday.Massachusetts-based Advanced Cell Technology said ...
WASHINGTON (Reuters) - U.S. doctors have begun treating the first patient to receive human embryonic stem cells, but details of the landmark clinical trial are being kept confidential, Geron Corp said on Monday.Geron has the first U.S. Food and Drug Administration license ...
